Literature DB >> 3289157

Timing of renal transplantation in the management of pyridoxine-resistant type I primary hyperoxaluria.

R W Watts1, S H Morgan, P Purkiss, M A Mansell, L R Baker, C B Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289157

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Oxalate, livers, and kidneys.

Authors:  R W Watts; M A Mansell
Journal:  BMJ       Date:  1990-10-06

2.  What treatment do you advise for a small child with hyperoxaluria presenting with renal calculi?

Authors:  R W Watts
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

3.  Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.

Authors:  H Ruder; G Otto; R B Schutgens; U Querfeld; R J Wanders; K H Herzog; P Wölfel; S Pomer; K Schärer; G A Rose
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

Review 4.  Factors governing urinary tract stone disease.

Authors:  R W Watts
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

5.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

Review 6.  Primary hyperoxaluria type I.

Authors:  K Latta; J Brodehl
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

Review 7.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

8.  Transplantation outcomes in patients with primary hyperoxaluria: a systematic review.

Authors:  Elisabeth L Metry; Liza M M van Dijk; Hessel Peters-Sengers; Michiel J S Oosterveld; Jaap W Groothoff; Rutger J Ploeg; Vianda S Stel; Sander F Garrelfs
Journal:  Pediatr Nephrol       Date:  2021-04-08       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.